These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 18513931)

  • 1. A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL).
    Popmihajlov Z; Pang L; Brown E; Joshi A; Su SC; Kaplan SS; Willis ED
    Hum Vaccin Immunother; 2018; 14(12):2916-2920. PubMed ID: 30024827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvements in the Tolerability Profile of 2'-
    Partridge W; Xia S; Kwoh TJ; Bhanot S; Geary RS; Baker BF
    Nucleic Acid Ther; 2021 Dec; 31(6):417-426. PubMed ID: 34242101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ND0701, A Novel Formulation of Apomorphine for Subcutaneous Infusion, in Comparison to a Commercial Apomorphine Formulation: 28-Day Pharmacokinetic Study in Minipigs and a Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Relative Bioavailability.
    Ramot Y; Nyska A; Adar L; Durlach C; Fishelovitch D; Sacco G; Manno RA; Oren S; Perlstein I; Yacobi-Zeevi O
    CNS Drugs; 2018 May; 32(5):443-454. PubMed ID: 29637529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injection site reactions after subcutaneous oligonucleotide therapy.
    van Meer L; Moerland M; Gallagher J; van Doorn MB; Prens EP; Cohen AF; Rissmann R; Burggraaf J
    Br J Clin Pharmacol; 2016 Aug; 82(2):340-51. PubMed ID: 27061947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense-mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first-in-human randomized, placebo-controlled trial.
    van Poelgeest EP; Hodges MR; Moerland M; Tessier Y; Levin AA; Persson R; Lindholm MW; Dumong Erichsen K; Ørum H; Cohen AF; Burggraaf J
    Br J Clin Pharmacol; 2015 Dec; 80(6):1350-61. PubMed ID: 26261033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Side effects of drugs. XI. Diagnostic preparations, vaccines, serotherapy, infusions, injection therapy].
    Saxl O; Skoupá M; Skoupý M
    Lek Veda Zahr; 1967 Dec; 12():232-5. PubMed ID: 4874500
    [No Abstract]   [Full Text] [Related]  

  • 7. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous drug reactions.
    Rees RB
    Tex Med; 1970 Feb; 66(2):92-3. PubMed ID: 4245512
    [No Abstract]   [Full Text] [Related]  

  • 10. High dose selection in general toxicity studies for drug development: A pharmaceutical industry perspective.
    Buckley LA; Dorato MA
    Regul Toxicol Pharmacol; 2009 Aug; 54(3):301-7. PubMed ID: 19477212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictivity of animal studies for human injection site reactions with parenteral drug products.
    Engelhardt JA
    Exp Toxicol Pathol; 2008 Aug; 60(4-5):323-7. PubMed ID: 18513931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: is 6 months still appropriate?
    Clarke J; Hurst C; Martin P; Vahle J; Ponce R; Mounho B; Heidel S; Andrews L; Reynolds T; Cavagnaro J
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):2-22. PubMed ID: 17998153
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.